Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2 Parts (Part 1 and 2).
Clinical trial NCT03370640 · COMPLETED
Trial details
- NCT number
- NCT03370640
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2018-09-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.